Initial Public Offering. IPO. Financial trade. Investment

Andranik Hakobyan

Hypertension drug developer Mineralys Therapeutics (MLYS) has filed for a $100M initial public offering.

The biotech company didn’t specify in its filing the price or number of shares to be offered, but indicated in its filing

Image and article originally from Read the original article here.

By admin